Showing results (21-30 of 366) with videos related to
Sort By:
Pageof 37
Mechanisms of Ageing and Development|May 13, 1985
The facilitation of dopaminergic activity in the aged brain by (-)deprenyl. A proposal for a strategy to improve the quality of life in senescenceJ KnollMonographs of the American Association on Mental Retardation|January 1, 1992
Being a family. The experience of raising a child with a disability or chronic illnessJ KnollJournal of Neural Transmission. Supplementum|January 1, 1993
The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseasesJ KnollActa Physiologica Et Pharmacologica Bulgarica|January 1, 1977
Azidomorphines and homopyrimidazols: a new approach to the ideal analgeticJ KnollActa Neurologica Scandinavica. Supplementum|January 1, 1983
Deprenyl (selegiline): the history of its development and pharmacological actionJ KnollMechanisms of Ageing and Development|December 1, 1988
The striatal dopamine dependency of life span in male rats. Longevity study with (-)deprenylJ KnollBiomedica Biochimica Acta|January 1, 1985
Satietin, a blood-borne, highly selective and potent anorectic glycoproteinJ KnollVoprosy Meditsinskoi Khimii|March 21, 1998
[History of deprenyl--the first selective inhibitor of monoamine oxidase type B]J KnollPharmacology & Toxicology|May 1, 1992
The pharmacological profile of (-)deprenyl (selegiline) and its relevance for humans: a personal viewJ KnollPageof 37